#14;ERYNGIOSIDE-K;21-BETA-ANGELOYLOXY-22-ALPHA-ACETYLOXY-O-3-BETA-[BETA-D-GLUCOPYRANOSYL-(1->2)]-[BETA-D-XYLOPYRANOSYL-(1->3)]-BETA-D-GLUCORONOPYRANOSYLOXY-OLE
Compound with spectra: 1 NMR
![#14;ERYNGIOSIDE-K;21-BETA-ANGELOYLOXY-22-ALPHA-ACETYLOXY-O-3-BETA-[BETA-D-GLUCOPYRANOSYL-(1->2)]-[BETA-D-XYLOPYRANOSYL-(1->3)]-BETA-D-GLUCORONOPYRANOSYLOXY-OLE](/api/compound/3A9aLI2OAP8.png?ph=true&h=300&w=458 "#14;ERYNGIOSIDE-K;21-BETA-ANGELOYLOXY-22-ALPHA-ACETYLOXY-O-3-BETA-[BETA-D-GLUCOPYRANOSYL-(1->2)]-[BETA-D-XYLOPYRANOSYL-(1->3)]-BETA-D-GLUCORONOPYRANOSYLOXY-OLE")
| SpectraBase Compound ID | 3A9aLI2OAP8 |
|---|---|
| InChI | InChI=1S/C54H84O22/c1-11-23(2)45(68)76-42-43(70-24(3)57)54(22-56)26(18-49(42,4)5)25-12-13-30-51(8)16-15-32(50(6,7)29(51)14-17-52(30,9)53(25,10)19-31(54)59)72-48-41(75-47-37(64)35(62)34(61)28(20-55)71-47)39(38(65)40(74-48)44(66)67)73-46-36(63)33(60)27(58)21-69-46/h11-12,26-43,46-48,55-56,58-65H,13-22H2,1-10H3,(H,66,67)/b23-11-/t26-,27+,28+,29-,30+,31+,32-,33-,34+,35-,36+,37+,38-,39-,40-,41+,42-,43-,46-,47-,48+,51-,52+,53+,54-/m0/s1 |
| InChIKey | JNZRVUUXJGGFKC-ISHUMXQOSA-N |
| Mol Weight | 1085.2 g/mol |
| Molecular Formula | C54H84O22 |
| Exact Mass | 1084.545424 g/mol |
| Enantiomer InChIKey | JNZRVUUXJGGFKC-FJGRZIDWSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
(2S,5R,6R,10R,12S,13S,14S,15R)-2-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2,5-bis(tert-butyldimethylsilyloxy)-13,15-isopropylidenedioxy-6-(4-methoxybenzyloxy)-10,12-dimethylheptadec-7-yn-9-one1-yne
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
(2R,3R,4S,6E,8R,9S,10S,11R,12R,13R)-1-tert-Butyldimethylsilyloxy-2,4,6,8,10,12-hexamethyl-3-(3,4-dimethoxybenzyloxy)-9,11-isopropylidenedioxy-13-(4-methoxybenzyloxy)-12-methoxymethoxypentacec-6-en-5-one
Diethyl 4,4''-{[(1R,2R)-cyclohexane-1,2-diyl]dinitrilo-3,3,3',3'-tetramethyl-4,4'-[(2",3",7",8"-tetrahydro-2",2",3",3",7",7",8',8'-octamethyl-11"H-dipyrrin-1",9"-diylidene)-dinitrilo]-bis[butanoato](1-)cobalt(III)
| Title | Journal or Book | Year |
|---|---|---|
| Phenolic compounds and rare polyhydroxylated triterpenoid saponins from Eryngium yuccifolium | Phytochemistry | 2008 |